Predictors of the DR of CRC, advanced adenoma and AN at the third FIT
| CRC | Advanced adenoma | AN | |||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | ||
| G ender | Women | 1 | 1 | 1 | |||
| Men | 1.34 | 1.00 to 1.79 | 1.63 | 1.46 to 1.83 | 1.60 | 1.43 to 1.78 | |
|
A
ge
(years) | 50– 54 | 0.54 | 0.32 to 0.91 | 0.67 | 0.55 to 0.82 | 0.65 | 0.55 to 0.79 |
| 55– 59 | 0.75 | 0.47 to 1.17 | 1.02 | 0.86 to 1.22 | 0.98 | 0.83 to 1.15 | |
| 60– 64 | 0.95 | 0.67 to 1.36 | 1.00 | 0.86 to 1.16 | 0.99 | 0.87 to 1.14 | |
| 65– 69 | 1 | 1 | 1 | ||||
|
I
nterval since last fit
(months) | 18– 22 | 0.67 | 0.30 to 1.49 | 0.80 | 0.59 to 1.08 | 0.78 | 0.58 to 1.03 |
| 23– 27 | 1 | 1 | 1 | ||||
| 28– 32 | 0.92 | 0.61 to 1.37 | 0.98 | 0.83 to 1.16 | 0.97 | 0.83 to 1.13 | |
| 33– 36 | 0.96 | 0.39 to 2.40 | 1.23 | 0.86 to 1.77 | 1.19 | 0.85 to 1.67 | |
| 37– 60 | 1.10 | 0.51 to 2.36 | 1.49 | 1.14 to 2.00 | 1.44 | 1.11 to 1.87 | |
|
Cumulative f-Hb level at previous 2 FIT tests
(FIT1 + FIT 2 ) μg Hb /g faeces | 0 | 1 | 1 | 1 | |||
| 0.1 – 3.9 | 2.26 | 1.47 to 3.46 | 1.75 | 1.47 to 2.07 | 1.81 | 1.55 to 2.12 | |
| 4 – 9.9 | 4.01 | 2.51 to 6.39 | 4.64 | 3.93 to 5.49 | 4.58 | 3.91 to 5.36 | |
| 10 – 14.9 | 10.11 | 6.04 to 16.93 | 9.13 | 7.48 to 11.15 | 9.32 | 7.73 to 11.23 | |
| 15 – 19.9 | 11.63 | 6.42 to 21.07 | 12.84 | 10.32 to 16.00 | 12.42 | 10.43 to 15.76 | |
| ≥ 20 | 38.92 | 22.50 to 67.31 | 30.40 | 24.09 to 38.38 | 32.52 | 26.19 to 40.39 | |
AN, advanced neoplasia; CRC, colorectal cancer; DR, detection rate; FIT, faecal immunochemical test.